Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave

Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave

Background: Critically ill COVID-19 patients have proven to be at risk for developing invasive fungal infections. However, the incidence and impact of possible/probable COVID-19-associated pulmonary aspergillosis (CAPA) in severe COVID-19 patients varies between cohorts. We aimed to assess the incid...

Full description

Bibliographic Details
Main Authors: Robbert G. Bentvelsen, Andreas L. E. Van Arkel, Tom A. Rijpstra, Merijn K. M. Kant, Simone Van Der Sar-Van Der Brugge, Daan W. Loth, Peter Van Wijngaarden, Arthur W. F. Du Mée, David C. Y. Yick, Bram M. W. Diederen, Peter C. Wever, Alexander C. A. P. Leenders, Laura Van Dommelen, Klaas H. De Groot, Wouter Van den Bijllaardt, Paul E. Verweij
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Journal of Fungi
Subjects:
COVID-19
pulmonary aspergillosis
CAPA
corticosteroids
voriconazole
Online Access:https://www.mdpi.com/2309-608X/8/2/96

Internet

https://www.mdpi.com/2309-608X/8/2/96

Similar Items